Navigation Links
Conformetrix Appoints Dr Sam Williams as Chief Executive Officer
Date:3/7/2012

MANCHESTER, England, March 7, 2012 /PRNewswire/ --

The Board of Conformetrix Ltd, a leader in optimising drug discovery and design, has appointed Dr Sam Williams as Chief Executive Officer, it is announced today. Dr Williams, who has extensive transactional and business development expertise, was previously a Non-Executive Director of the company. He takes over from one of Conformetrix's founder scientists, Dr Andrew Almond, who becomes Chief Technology Officer.

Conformetrix uses its NMR-based technology to determine the accurate bioactive structures of molecules, an approach which has significant potential in the optimisation of drug discovery and design, as well as the generation of novel drugs. By solving dynamic 3D structures independently of techniques such as X-ray crystallography, the Conformetrix approach derives valuable data more quickly and cheaply than standard approaches. It has been validated by studies both in-house and with partners, and further data and partnering deals are expected this year.

Prior to moving into company management, Dr Williams spent over a decade in the City as a top-rated[1] healthcare analyst, with Robertson Stephens and Lehman Brothers. As well as advising on life sciences investments, he was involved in several IPOs and M&A transactions. Sam has a biology degree from the University of Oxford and a PhD from the University of Cambridge. He will combine his duties at Conformetrix with his role as CEO of Modern Biosciences, a virtual drug development company.

Dr Clive Dix, Chairman of Conformetrix, said, "We welcome Sam as CEO of Conformetrix, where his expertise will be invaluable as the company enters this important next phase of its development. The Board's thanks are also due to Andrew and to Chief Scientific Officer and fellow founder Dr Charles Blundell for their significant contribution to the company's growth so far."

Dr Sam Williams, CEO of Conform
'/>"/>

SOURCE Conformetrix Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Idenix Pharmaceuticals Elects Thomas Hodgson as Chairman of the Board and Appoints Michael Wyzga to Its Board of Directors
2. Codexis Appoints Interim Chief Executive Officer
3. Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors
4. UBM Live Appoints Jim Buckley as Informex Brand Director
5. Samsung Medison America Appoints Michael Podany as Vice President of Sales, West USA
6. Savient Pharmaceuticals Appoints David Y. Norton Interim Chief Executive Officer
7. Savient Pharmaceuticals Appoints Experienced Pharmaceutical Executive, David Veitch as President of Savient Europe
8. Biosyntrx, Inc. Appoints New Board Member & New VP of Operations
9. Octapharma USA Appoints Global Biopharmaceutical Executive David E. Holliday as Vice President of Commercial Development
10. Essentialis Appoints Mahendra G. Shah, Ph.D., to Board of Directors
11. PrimeraDx Appoints David Jackson as VP of Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5sqnn3/global_rising ) ... Stars Outlook 2015" report to their offering. ... sought after with fresh vigor as new targets , ... poised to bring a paradigm change in the way ... Stem cell therapy/Regenerative Medicine space. The number ...
(Date:3/5/2015)... DUBLIN , Mar. 05, 2015 Research ... announced the addition of Jain PharmaBiotech,s new report ... Companies" to their offering. ... multi-disciplinary clinical specialty, aimed at improving patient care ... individually adjust the dose of drugs for improving ...
(Date:3/5/2015)... March 5, 2015  MGC Diagnostics Corporation (NASDAQ: ... company, today reported financial results for the first ... 2015 first quarter domestic equipment, supplies and accessories ... $3.7 million in the 2014 first quarter.  During ... or $338,000 in revenue, compared to 14 accounts, ...
Breaking Medicine Technology:Global Pharma Rising Stars Outlook 2015 2Global Therapeutic Drug Monitoring Report 2015 - Technologies, Markets, and Companies Analysis 2014-2024 2MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 2MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 3MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 4MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 5MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 6MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 7MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 8MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 9MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 10MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 11MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 12
... (Nasdaq: ATHX ), a clinical stage ... Retail Investor Conferences.com presentation is available for on-demand ... Executive Officer of Athersys, presented to retail investors ... To view the archived presentation, click on ...
... Corporation, a privately held, clinical stage biopharmaceutical company developing ... today announced the appointment of Dr. Dennis Fenton, long-time ... Fenton,s appointment expands the Genelux Corporation board to 5 ... build one of the world,s most successful pharmaceutical companies ...
Cached Medicine Technology:Athersys, Inc. - Retail Investor Conferences.com Presentation Now Available Online 2Genelux Corporation Expands Board of Directors, Appointing Dennis Fenton, Former Amgen Executive 2
(Date:3/5/2015)... 05, 2015 Supply & Demand Chain ... of “Pros to Know” in the supply chain industry, ... of MEBC’s leadership team were included on this year’s ... received this award due to their hard work, their ... for meeting and resolving client needs and challenges. ...
(Date:3/5/2015)... New York, NY (PRWEB) March 05, 2015 ... NY orthopedic Surgeon ( http://www.orthopedicsurgeonnyc.com ) has been named ... in the New York Metro area. Dr. Glashow has ... in its authoritative guide to the top specialty care ... 2015. , The prestigious Castle Connolly program, which carefully ...
(Date:3/5/2015)... March 05, 2015 As a ... (AAPA) review of Clearstream, LLC ’s products, ... Clearstream’s MediDefense line of products—led by their mPulse ... Affinity Partner Program. , The AAPA—which represents a ... all medical and surgical specialties in the U.S.—advocates ...
(Date:3/5/2015)... Diego, CA (PRWEB) March 05, 2015 ... it is now running on 100% pollution-free electricity ... Arcadia Power. , As an Arcadia Power ... Protection Agency’s (EPA) Green Power Partnership requirements, joining ... Starbucks that also purchase clean energy. Earth Source ...
(Date:3/5/2015)... Park, California (PRWEB) March 05, 2015 ... (JCAP) last week released a special issue ... in the field of PANDAS (Pediatric Autoimmune Neuropsychiatric ... Neuropsychiatric Syndromes), an autoimmune reaction triggered by infections ... lyme, which result in inflammation of the child's ...
Breaking Medicine News(10 mins):Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Dr. Jonathan Glashow, NYC Orthopedic Surgeon, Named Top Doctor: New York Metro Area 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4Health News:Earth Source Organics to Run on Clean Energy from Arcadia Power 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 3
... 2007) -- A University of South Florida fetal surgeon ... rare but potentially devastating condition in which placental blood ... labor, leaving the baby without vital blood and oxygen. ... frequently deadly for newborns. , The case was ...
... delaying surgical treatment remains the standard of care for ... in the December issue of the Journal of the ... belief, early cholecystectomy -- or surgical removal of the ... mild to moderate gallstone pancreatitis with no increase in ...
... Inc. (Nasdaq:,CYBX) announced that effective December 18, 2007, ... Endo-Surgery granting exclusive rights to,the company,s patents and ... the treatment of obesity and two related,co-morbidities, diabetes ... has agreed to pay Cyberonics a signing fee ...
... 18 DuPont has selected,its Cooper River plant ... announced to significantly expand production of high-performance,DuPont(TM) Kevlar(R) ... The investment at the Cooper River site, which ... Berkeley County, will include construction of,a new Kevlar(R) ...
... WALTHAM, Mass., Dec. 18 Art Mellor is one ... million worldwide suffering from,Multiple Sclerosis (MS). It,s, a debilitating ... other,symptoms. So it,s no wonder that Mellor, the founder ... interested in snow and more,interested in raising the funds ...
... 17, 2007) -- The Leon Levy Foundation has ... Hospital/Weill Cornell Medical Center in New York City ... neurological disorders: chemotherapy-related cognitive dysfunction in adult cancer ... as "water on the brain," a progressive neurologic ...
Cached Medicine News:Health News:Fetal surgeon shows for first time that laser procedure may treat vasa previa 2Health News:Fetal surgeon shows for first time that laser procedure may treat vasa previa 3Health News:Early surgical treatment contributes to better outcomes in gallstone pancreatitis cases 2Health News:Cyberonics Licenses Obesity-Related Patents 2Health News:Cyberonics Licenses Obesity-Related Patents 3Health News:DuPont Selects South Carolina Site for Planned $500 Million Investment to Expand Production of High-Performance Kevlar(R) Fiber 2Health News:DuPont Selects South Carolina Site for Planned $500 Million Investment to Expand Production of High-Performance Kevlar(R) Fiber 3Health News:DuPont Selects South Carolina Site for Planned $500 Million Investment to Expand Production of High-Performance Kevlar(R) Fiber 4Health News:DuPont Selects South Carolina Site for Planned $500 Million Investment to Expand Production of High-Performance Kevlar(R) Fiber 5Health News:This Holiday Season Some Dream of a White Christmas - The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis 2Health News:This Holiday Season Some Dream of a White Christmas - The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis 3Health News:$1.4 million grant awarded to study 2 little-understood neurological disorders 2
... unique lateral fiber possessing a ... rotated to any one of ... fibers in one. The fiber ... and coagulation and back to ...
... the first truly lateral, all quartz fiber. ... (NA) compression technology for Total Internal Reflection ... The resulting output is virtually indistinguishable from ... transmission efficiency in a round spot of ...
Stirrups provide a safe system for positioning patients in a variety of lithotomy positions. Power-assisted positioning, as well as abduction, assures proper positioning of the patient. Includes one ...
Use to prevent arm or leg drops during surgical procedures. The dimensions are 10"W x 6"H. These come in pairs. Optional Gel pad available (BD2245)...
Medicine Products: